Visual function and retinal morphological changes after single suprachoroidal delivery of fluocinolone acetonide (Iluvien®) implant in eyes with chronic diabetic macular edema. [PDF]
Int J Retina Vitreous, 2023 El Rayes EN, Leila M.
europepmc +1 more source
Efficacy and Safety of Fluocinolone Acetonide Implant in Diabetic Macular Edema: Practical Guidelines from Reference Center. [PDF]
PharmaceuticsSejournet L +6 more
europepmc +1 more source
Intravitreal Fluocinolone Acetonide Implant (FAc, 0.19 mg, ILUVIEN®) in the Treatment of Patients with Recurrent Cystoid Macular Edema After Pars Plana Vitrectomy. [PDF]
Ophthalmol Ther, 2023 Lima-Fontes M +7 more
europepmc +1 more source
Fluocinolone Acetonide Implant for Uveitis: Dissecting Responder and Non-Responder Outcomes at a Tertiary Center. [PDF]
BiomedicinesAbu Arif J +7 more
europepmc +1 more source
Consideration for Expanding the Audiology Scope of Practice to Include Prescription Medication Authority [PDF]
The demand for medical professionals rises in conjunction with the rise of prescriptions written annually in the United States, but there are not enough physicians to meet the demand for patient prescriptions (Mohamadloo et al., 2019).
Gill, Erin Grace
core +1 more source
The effectiveness of the 0.19 mg fluocinolone acetonide implant in treating non-infectious posterior uveitis: a real-world experience. [PDF]
J Ophthalmic Inflamm InfectKozak I, Gurbaxani A, Pandova M.
europepmc +1 more source
Fluocinolone acetonide 0.18-mg implant for treatment of recurrent inflammation due to non-infectious uveitis: a case series of 15 patients. [PDF]
J Ophthalmic Inflamm InfectSisk RA +5 more
europepmc +1 more source
Factors associated with the response to fluocinolone acetonide 0.19 mg in diabetic macular oedema evaluated as the area-under-the-curve. [PDF]
Eye (Lond), 2023 Cicinelli MV +5 more
europepmc +1 more source